Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the […]
ValleyScare is Back from the Dead!
Shakopee, MN, April 02, 2024 (GLOBE NEWSWIRE) — Officials at Valleyfair today announced the return of ValleyScare, Minnesota’s largest Halloween […]
COMSTOCK RESOURCES, INC. ANNOUNCES PRIVATE OFFERING OF 6.75% SENIOR NOTES DUE IN 2029
FRISCO, TX, April 02, 2024 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (“Comstock” or the “Company”) (NYSE: CRK) announced today that, […]
TSX News -
Erdene Announces Year-End Results and Provides Bayan Khundii Project Update
HALIFAX, Nova Scotia, April 02, 2024 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) (“Erdene” or the “Company”) is […]
TSX News -
Else Nutrition Announces Highly Anticipated First Commercial Launch of its Groundbreaking Plant-Based Infant Formula in Australia; Also Targeting $50B (USD) Plus Asia Pacific Baby & Child Nutrition Markets
Australia Strategically Selected as Beachhead for Commercial Expansion of Else Products Across the Asia Pacific Region Amazon First to Carry […]
TSX News -
Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
Transaction consideration provides a significant premium to the Appili shareholders Combined enterprise expected to provide enhanced synergies and resources to […]
TSX News -
Avicanna Reports Full Year 2023 Audited Financial Results
$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022 […]
Bitcoin Well Announces BTC Sessions Partnership
EDMONTON, Alberta, April 02, 2024 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), […]
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Year marked by growing body of promising data demonstrating Ampligen’s potential to address multiple high-value indications Company to host conference […]
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
MALVERN, Pa., April 02, 2024 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug […]
